CSIC Delegation in the Region of Valencia

A US team analyzed the genetic activity of individual brain cells from 15 men and 15 women and found 133 genes that showed consistent differences. Although biological sex explained only a small part of the differences they found when comparing all the brains, variants in many of these genes have been associated with neuropsychiatric and neurodegenerative disorders—such as ADHD, schizophrenia, depression, and Alzheimer's—suggesting that sex differences could play a role in the distinct risk men and women have of developing certain diseases. The authors, however, acknowledge that the sex-related differences in their study could stem from differences in socialization and experience. The results are published in Science.  

A review of studies conducted by the Cochrane Collaboration analyzed data from 17 clinical trials involving more than 20,000 participants who had been treated with amyloid-targeting drugs—such as lecanemab or donanemab—at a relatively early stage of Alzheimer’s disease. Results at 18 months of treatment show that “the absolute effects on cognitive decline and the severity of dementia were nonexistent or negligible, falling well below the thresholds established for a clinically meaningful difference,” according to a press release. Furthermore, the review concludes that these drugs likely cause more brain inflammation and microbleeds than the placebo.

A clinical trial (COSMOS) involving 958 healthy adults with an average age of 70 tested the ability of a multivitamin supplement, together with cocoa extract, to slow ageing. The results, published in Nature Medicine, show that the supplement slightly slowed two of the five biological markers of ageing measured after two years of daily use. The two markers affected were PCPhenoAge and PCGrimAge, whose rate of increase was reduced by 2.6 months and 1.4 months respectively. The slowing effect was greater among participants who initially showed more accelerated ageing. Cocoa showed no effect.

CAR-T cells, T lymphocytes modified in the laboratory to attack tumor cells, have shown promise against certain types of cancer. Now, a US team has followed the same concept and introduced artificial receptors into astrocytes, a type of nerve cell, with the aim of reducing the amyloid plaques characteristic of Alzheimer's disease. The experiments, conducted in mice, showed a significant reduction in amyloid, although no changes in the animals' behavior were observed. The results are published in Science. 

Science journal has published a global map showing exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) through the consumption of fish products. PFAS are substances that are difficult to break down, meaning they can accumulate in the body, and some are linked to health problems. The authors collected data over 20 years from PFAS measurements in the marine environment and fisheries, and mapped the concentrations of these compounds in more than 200 species of marine fish. The study shows that international fish trade redistributes the risk of PFAS exposure from highly polluted regions to less exposed areas, with European trade playing a key role in increasing the risk of exposure to these substances. 

A team from the United States has used data from health studies to analyze the extent to which prestigious journals capture or ignore science considered influential. Their findings indicate that most of the most cited articles—thus considered most influential—are published in journals not ranked among the most prestigious. According to the study, approximately half of all researchers never publish in a journal with an impact factor above 15, which, according to certain evaluation systems, could exclude them from opportunities. However, overall, traditional journal-based measures may only recognize between 10% and 20% of influential work. The results are published in Plos Biology. 

Consuming up to four cups of coffee a day is associated with an increase in telomere length in people with severe mental disorders, such as schizophrenia or bipolar disorder. Telomere length is an indicator of cellular ageing and is shorter in people with these disorders, although the causes are not clearly understood. According to the study, published in BMJ Mental Health, the effect shown is comparable to ‘a biological age five years younger’ in coffee drinkers. 

Most rare diseases are caused by mutations in DNA, but the same gene can mutate in different ways, which complicates treatment. Now, a team from the CRG in Barcelona has shown that an already approved drug is capable of stabilising almost all mutated versions of a human protein—specifically, the vasopressin V2 receptor, which is linked to a rare disease called nephrogenic diabetes insipidus. According to the researchers, who published their findings in Nature Structural & Molecular Biology, the study is the first proof of concept demonstrating that a drug can act as a ‘near-universal’ treatment, which could accelerate the development of therapies.

Cosmological models suggest that matter and antimatter were created in equal amounts in the Big Bang, but in the current universe matter seems to predominate over antimatter. This imbalance is believed to be due to differences in the behaviour of the two, a violation of symmetry known as CP violation. This effect was predicted by the Standard Model of Physics and observed experimentally in mesons more than 60 years ago. Now, the LHCb collaboration at CERN, which includes significant Spanish participation, has observed this phenomenon for the first time in the decay of baryons, particles that make up most of the matter in the observable universe. The study is published in Nature.

The KATRIN (Karlsruhe Tritium Neutrino Experiment) team has published the most accurate measurement to date of the upper limit of the neutrino mass in the journal Science, establishing it at 0.45 electronvolts (eV), less than a millionth of the mass of an electron. The KATRIN experiment, launched in 2018 in Germany, will finalise its neutrino mass measurement campaign this year, having reached 1,000 days of data acquisition.